首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Monoclonal antibodies in immunodiagnosis and immunotherapy

缩写:

ISSN:2167-9436

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引652
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yu Isoda,Tomohiro Tanaka,Hiroyuki Suzuki et al. Yu Isoda et al.
An anti-mouse CXC chemokine receptor 6 (mCXCR6) monoclonal antibody (mAb), Cx6Mab-1, was developed recently. Cx6Mab-1 is applicable for flow cytometry, Western blotting, and enzyme-linked immunosorbent assay. The purpose of this study is to...
Teizo Asano,Tomohiro Tanaka,Hiroyuki Suzuki et al. Teizo Asano et al.
The CC chemokine receptor 6 (CCR6) is a G protein-coupled receptor family member that is highly expressed in B lymphocytes, certain subsets of effector and memory T cells, and immature dendritic cells. CCR6 has only one chemokine ligand, CC...
Tomohiro Tanaka,Hiroyuki Suzuki,Yu Isoda et al. Tomohiro Tanaka et al.
The C-C chemokine receptor 9 (CCR9) belongs to the G-protein-coupled receptor superfamily, and is highly expressed on the T cells and intestinal cells. CCR9 regulates various immune responses by binding to the C-C chemokine ligand, CCL25, a...
Hiroyuki Suzuki,Teizo Asano,Tomokazu Ohishi et al. Hiroyuki Suzuki et al.
Human epidermal growth factor receptor 2 (HER2) is a cell surface type I transmembrane glycoprotein that is overexpressed on a variety of solid tumors and transduces the oncogenic signaling upon homo- and heterodimerization with HER familie...
Tomohiro Tanaka,Hiroyuki Suzuki,Teizo Asano et al. Tomohiro Tanaka et al.
CC chemokine receptor type-2 (CCR2) is a member of the G protein-coupled receptors, and is mainly expressed on cell surface of immune cells. CCR2 binds to its ligand, C-C motif chemokine 2 (also named as monocyte chemoattractant protein-1),...
Nripendra Nath Mishra,Anu Sharma,Swati Shalini et al. Nripendra Nath Mishra et al.
In past few years many rituximab (RTX) biosimilars have been launched in India. Biosimilars are products that are similar in terms of quality, safety, and efficacy to its innovator product and are expected to offer improved affordability. T...
Anastas Pashov,Ramachandran Murali,Issam Makhoul et al. Anastas Pashov et al.
Targeting the diverse glycan repertoire expressed on tumor cells is considered a viable therapeutic strategy to deal with tumor cell heterogeneity. Inherently polyspecific, natural, glycan-reactive antibodies are purported to be protective ...
Masaki Saito,Hiroyuki Suzuki,Teizo Asano et al. Masaki Saito et al.
Immune checkpoint molecules have received attention as targets of cancer immunotherapy. Killer cell lectin-like receptor subfamily G member 1 (KLRG1) is one of the immune checkpoint molecules expressed in CD4+ T, CD8+ T, and natural killer ...
Yu Isoda,Tomohiro Tanaka,Hiroyuki Suzuki et al. Yu Isoda et al.
The CXC chemokine receptor 6 (CXCR6) is a member of the G protein-coupled receptor family that is highly expressed in helper T type 1 cells, cytotoxic T lymphocytes (CTLs), and natural killer cells. CXCR6 plays critical roles in local expan...